The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1867017203855917056 |
|---|---|
| author | William J. Nahm Vincent Falanga |
| author_facet | William J. Nahm Vincent Falanga William J. Nahm Vincent Falanga |
| collection | Wiley Open Access |
| contents | The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair William J. Nahm Vincent Falanga International Wound Journal ABSTRACTTyrosine kinase inhibitors (TKIs) can treat various cancers, primarily through their antiangiogenic effects. However, as angiogenesis is crucial for successful wound healing, TKIs may adversely impact wound repair. This review analysed all 63 FDA‐approved TKIs and identified evidence for wound healing and repair implications in 24 agents. The primary mechanism contributing to impaired wound healing appears to be the inhibition of vascular endothelial growth factor receptors, with secondary targets, such as epidermal growth factor receptors and platelet‐derived growth factor receptors, potentially playing a role. Information from safety package inserts, preclinical studies, case reports and clinical trials suggests that these TKIs can cause delayed or impaired wound healing. The safety information generally recommends discontinuing treatment for at least one to 2 weeks before elective surgery and resuming treatment only after adequate wound healing has occurred. Neoadjuvant therapy with TKIs may be feasible if sufficient time is allowed between the cessation of the TKI and the onset of surgery. As the use of TKIs continues to increase, healthcare professionals should be aware of their potential impact on wound healing and take appropriate precautions to minimise the risk of wound‐related complications. 10.1111/iwj.70513 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1111/iwj.70513 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_iwj_70513 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair William J. Nahm Vincent Falanga International Wound Journal The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair William J. Nahm Vincent Falanga International Wound Journal ABSTRACTTyrosine kinase inhibitors (TKIs) can treat various cancers, primarily through their antiangiogenic effects. However, as angiogenesis is crucial for successful wound healing, TKIs may adversely impact wound repair. This review analysed all 63 FDA‐approved TKIs and identified evidence for wound healing and repair implications in 24 agents. The primary mechanism contributing to impaired wound healing appears to be the inhibition of vascular endothelial growth factor receptors, with secondary targets, such as epidermal growth factor receptors and platelet‐derived growth factor receptors, potentially playing a role. Information from safety package inserts, preclinical studies, case reports and clinical trials suggests that these TKIs can cause delayed or impaired wound healing. The safety information generally recommends discontinuing treatment for at least one to 2 weeks before elective surgery and resuming treatment only after adequate wound healing has occurred. Neoadjuvant therapy with TKIs may be feasible if sufficient time is allowed between the cessation of the TKI and the onset of surgery. As the use of TKIs continues to increase, healthcare professionals should be aware of their potential impact on wound healing and take appropriate precautions to minimise the risk of wound‐related complications. 10.1111/iwj.70513 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | The Adverse Impact of Tyrosine Kinase Inhibitors on Wound Healing and Repair |
| topic | International Wound Journal |
| url | https://onlinelibrary.wiley.com/doi/10.1111/iwj.70513 |